Mermoud et al., 1993 - Google Patents
Surgical management of post-traumatic angle recession glaucomaMermoud et al., 1993
- Document ID
- 11763816752522810183
- Author
- Mermoud A
- Salmon J
- Barron A
- Straker C
- Murray A
- Publication year
- Publication venue
- Ophthalmology
External Links
Snippet
Purpose: The purpose of this study is to compare the results of three different drainage procedures performed for uncontrolled post-traumatic angle recession glaucoma. Methods: A retrospective analysis was undertaken of 87 drainage procedures performed on 65 …
- 208000010412 Glaucoma 0 title abstract description 52
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Method or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00802—Methods or devices for eye surgery using laser for photoablation
- A61F9/00817—Beam shaping with masks
- A61F9/00819—Beam shaping with masks with photoablatable masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/912—Ophthalmic
- Y10S514/913—Glaucoma
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mermoud et al. | Surgical management of post-traumatic angle recession glaucoma | |
| Aung et al. | Trabeculectomy for acute primary angle closure | |
| Stamper et al. | Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil | |
| US5767079A (en) | Method of treating ophthalmic disorders using TGF -β | |
| Shin et al. | Needling revision of failed filtering blebs with adjunctive 5-fluorouracil | |
| Gil-Carrasco et al. | Ahmed valve implant for uncontrolled uveitic glaucoma | |
| Liebmann et al. | Initial 5-fluorouracil trabeculectomy in uncomplicayed glaucoma | |
| Roberts et al. | Primary phacoemulsification for uncontrolled angle-closure glaucoma | |
| Jampel et al. | Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma | |
| Mermoud et al. | Trabeculectomy with mitomycin C for refractory glaucoma in blacks | |
| Rockwood et al. | Glaucoma filtering surgery with 5-fluorouracil | |
| Costa et al. | Hypotony maculopathy following the use of topical mitomycin C in glaucoma filtration surgery | |
| Asrani et al. | Management of bleb leaks after glaucoma filtering surgery: use of autologous fibrin tissue glue as an alternative | |
| JOHNSON et al. | Tissue plasminogen activator treatment of experimental subretinal hemorrhage | |
| Lee et al. | The effect of adjunctive mitomycin C in Molteno implant surgery | |
| Desai et al. | Use of perfluoroperhydrophenanthrene in the management of suprachoroidal hemorrhages | |
| CA2138644A1 (en) | Method of treating ophthalmic disorders using tgf-.beta. | |
| Hennis et al. | The use of 5-fluorouracil in patients following combined trabeculectomy and cataract extraction | |
| Durak et al. | The role of needle revision and 5-fluorouracil application over the filtration site in the management of bleb failure after trabeculectomy: a prospective study | |
| WO1996009838A1 (en) | METHOD OF TREATING MACULAR DEGENERATION USING TGF-$g(b) | |
| Mandal et al. | Mitomycin-C-augmented trabeculectomy for neovascular glaucoma. A preliminary report | |
| Prata Jr et al. | Postoperative complications and short-term outcome after 5-fluorouracil or mitomycin-C trabeculectomy | |
| Schwartz et al. | Resuturing the scleral flap leads to resolution of hypotony maculopathy | |
| Tsai et al. | Surgical revision of glaucoma shunt implants | |
| Smith et al. | Treatment of postfiltration bleb leak by bleb injection of autologous blood |